Clinical Trial

A Study of Dimdazenil in Patients With Parkinson's Disease and Insomnia

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study will use sleep parameters measured by polysomnography (PSG) as the primary means to evaluate the efficacy and safety of dimdazenil, a GABAA receptor partial agonist, in treating insomnia in Parkinson's disease patients.
Trial Details
NCT Number NCT07714772
Lead Sponsor Second Affiliated Hospital of Soochow University
Collaborators: The Fourth Affiliated Hospital of Soochow University, Changshu Hospital of Traditional Chinese Medicine, The Second Affiliated Hospital of Jiaxing University
Conditions Insomnia, Parkinson's Disease (PD)
Enrollment 50 participants
Start Date 2026-08-01
Primary Completion 2026-12-10 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-20